This report was recently updated on July 20 2024 with the latest and most recent
market numbers
Global Oncology Drug Discovery & Development Market Size, Trends & Analysis - Forecasts to 2028 By Drug/Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, and Others), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Leukemia Cancer, Lymphoma Cancer, Ovarian Cancer, and Others), By Stage (Discovery Phase, Preclinical Phase, and Clinical Trials & Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global oncology drug discovery & development market is projected to grow at a CAGR of 17.9% from 2023 to 2028.
The rising prevalence of cancer worldwide drives the demand for effective treatments, spurring research and development in this field. As per the World Health Organization (WHO), cancer is a prominent global cause of mortality, contributing to almost 10 million deaths in 2020, representing nearly one out of every six deaths.
Innovations in biotechnology, genomics, and precision medicine have led to more targeted and personalized cancer treatments. For instance, in February 2023, Roche, a pharmaceutical company, introduced two novel antibodies to detect critical mutations in individuals diagnosed with brain cancer. These antibodies are used for assessing a patient's brain tumor mutation status, mainly focusing on mutations in the IDH1 and ATRX genes.
Regulatory agencies provide avenues for accelerated approvals and orphan drug designations, facilitating the development of oncology drugs. For instance, in July 2023, the drug Enhertu (trastuzumab deruxtecan), developed by AstraZeneca and Daiichi Sankyo, received approval from China’s National Medical Products Administration (NMPA). The approval is for treating adult patients with HER2-low (IHC 1+ or IHC 2+/ISH-) breast cancer.
Targeted therapy segment is expected to hold the significant share of the market over the forecast period. The dominance is primarily attributed to its precision, reduced side effects, and enhanced efficacy compared to traditional chemotherapy. Targeted therapies are designed to specifically target the molecular and genetic alterations in cancer cells, sparing normal tissues and minimizing side effects, which improves patient tolerance and quality of life. By addressing the underlying drivers of cancer and reducing the risk of organ damage and cancer recurrence, targeted therapy has become a more patient-centric, effective, and safer approach.
Immunotherapy segment is expected to be the fastest-growing segment in the market from 2023-2028. This accelerated growth is attributed to the introduction of multiple drugs of this category by prominent industry leaders and extensive research and development initiatives by research organizations. For instance, in July 2020, Aichi Cancer Center and NEC Corporation unveiled a joint effort for foundational research intending to advance cancer immunotherapy through integrating artificial intelligence (AI) in the field of immunology.
Lung cancer segment is expected to hold the largest share of the market. This can be attributed to the rising incidence of lung cancer worldwide. Lung cancer stands out as the most widespread cancer, affecting a significant portion of the global population. Data from the International Agency for Research on Cancer reveals that in 2020, approximately 1.8 million fatalities were linked to lung cancer. Lung cancer is the primary contributor to cancer-related deaths, making up roughly 18% of the total global cancer mortality.
Breast cancer segment is anticipated to be the fastest-growing segment in the market from 2023-2028. The growth is attributed to the increasing number of cases reported for breast cancer. Additionally, the growing population contributes to discovering and developing breast cancer drugs. According to the Centers for Disease Control and Prevention, the likelihood of developing breast cancer rises as a person ages, with most breast cancer cases being detected in individuals aged 50 and above. Genetic mutations, specifically alterations in genes like BRCA1 and BRCA2, increase women's susceptibility to breast and ovarian cancers.
The preclinical phase segment is anticipated to be the fastest-growing segment in the market from 2023-2028. This segment encompasses crucial activities such as in-depth testing, safety assessments, and early efficacy evaluations, laying the groundwork for advancing potential cancer treatments. Increasing healthcare laboratory infrastructure and investment are contributing to the segment's growth.
The discovery phase segment holds the largest share of the market. This phase is critical in identifying and validating potential drug candidates for treating various forms of cancer. It involves intensive research, target identification, and preliminary testing, laying the foundation for developing effective oncology drugs.
North America is expected to be the largest region in the market. The primary reasons boosting the market growth in this region include the presence of prominent drug discovery service providers such as Thermo Fisher Scientific Inc. and Pfizer, among others. High expenditure on research and development, rising outsourcing of research and development services by pharmaceutical companies, and well-established healthcare infrastructure contribute to the region's oncology drug discovery and development market growth.
Asia Pacific is predicted to witness rapid growth during the forecast period. The anticipated market growth in the region is attributed to the increasing prevalence of complex cancer-related cases, which will further require efficient and effective drug discovery and development. Additionally, increasing healthcare expenditure contributes to the region's oncology drug discovery and development market growth.
F. Hoffmann-La Roche Ltd, Novartis, AstraZeneca, Merck & Co., Inc, Bristol-Myers Squibb, Pfizer, Eli Lilly and Company, Gilead Sciences, Regeneron Pharmaceuticals, and Takeda Pharmaceutical Company, among others, are some of the key players operating in the global oncology drug discovery & development market.
Please note: This is not an exhaustive list of companies profiled in the report.
On October 10, 2023, Merck, also known as MSD, announced the successful results of Phase 3 KEYNOTE-671 trial for its anti-PD-1 therapy, KEYTRUDA, in the treatment of resectable stage II, IIIA, or IIIB (T3-4N2) non-small cell lung cancer (NSCLC). The trial demonstrated statistically significant improvement in overall survival (OS) when KEYTRUDA was administered before and after surgery compared to neoadjuvant chemotherapy followed by adjuvant placebo.
On October 12, 2023, Pfizer received approval from the U.S. Food and Drug Administration (FDA) for the use of the drug combination BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) in the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) who possess a specific genetic mutation called BRAF V600E. This approval allows for a personalized treatment option for patients with this particular mutation, which can be identified using specific diagnostic tests.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL ONCOLOGY DRUG DISCOVERY & DEVELOPMENT MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL ONCOLOGY DRUG DISCOVERY & DEVELOPMENT MARKET, BY DRUG/THERAPY TYPE
4.1 Introduction
4.2 Oncology Drug Discovery & Development Market: Drug/Therapy Type Scope Key Takeaways
4.3 Revenue Growth Analysis, 2022 & 2028
4.4 Chemotherapy
4.4.1 Chemotherapy Market Estimates and Forecast, 2020-2028 (USD Million)
4.5 Targeted Therapy
4.5.1 Targeted Therapy Market Estimates and Forecast, 2020-2028 (USD Million)
4.6 Immunotherapy
4.6.1 Immunotherapy Market Estimates and Forecast, 2020-2028 (USD Million)
4.7 Hormone Therapy
4.7.1 Hormone Therapy Market Estimates and Forecast, 2020-2028 (USD Million)
4.8 Others
4.8.1 Others Market Estimates and Forecast, 2020-2028 (USD Million)
5 GLOBAL ONCOLOGY DRUG DISCOVERY & DEVELOPMENT MARKET, BY CANCER TYPE
5.1 Introduction
5.2 Oncology Drug Discovery & Development Market: Cancer Type Scope Key Takeaways
5.3 Revenue Growth Analysis, 2022 & 2028
5.4 Lung Cancer
5.4.1 Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Million)
5.5 Breast Cancer
5.5.1 Breast Cancer Market Estimates and Forecast, 2020-2028 (USD Million)
5.6 Colorectal Cancer
5.6.1 Colorectal Cancer Market Estimates and Forecast, 2020-2028 (USD Million)
5.7 Prostate Cancer
5.7.1 Prostate Cancer Market Estimates and Forecast, 2020-2028 (USD Million)
5.8 Leukemia Cancer
5.8.1 Leukemia Cancer Market Estimates and Forecast, 2020-2028 (USD Million)
5.9 Lymphoma Cancer
5.9.1 Lymphoma Cancer Market Estimates and Forecast, 2020-2028 (USD Million)
5.10 Ovarian Cancer
5.10.1 Ovarian Cancer Market Estimates and Forecast, 2020-2028 (USD Million)
5.11 Others
5.11.1 Others Market Estimates and Forecast, 2020-2028 (USD Million)
6 GLOBAL ONCOLOGY DRUG DISCOVERY & DEVELOPMENT MARKET, BY STAGE
6.1 Introduction
6.2 Oncology Drug Discovery & Development Market: Stage Scope Key Takeaways
6.3 Revenue Growth Analysis, 2022 & 2028
6.4 Discovery Phase
6.4.1 Discovery Phase Market Estimates and Forecast, 2020-2028 (USD Million)
6.5 Preclinical Phase
6.5.1 Preclinical Phase Market Estimates and Forecast, 2020-2028 (USD Million)
6.6 Clinical Trials & Others
6.6.1 Clinical Trials & Others Market Estimates and Forecast, 2020-2028 (USD Million)
7 GLOBAL ONCOLOGY DRUG DISCOVERY & DEVELOPMENT MARKET, BY REGION
7.1 Introduction
7.2 North America Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.2.1 By Drug/Therapy Type
7.2.2 By Cancer Type
7.2.3 By Stage
7.2.4 By Country
7.2.4.1 U.S. Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.2.4.1.1 By Drug/Therapy Type
7.2.4.1.2 By Cancer Type
7.2.4.1.3 By Stage
7.2.4.2 Canada Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.2.4.2.1 By Drug/Therapy Type
7.2.4.2.2 By Cancer Type
7.2.4.2.3 By Stage
7.2.4.3 Mexico Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.2.4.3.1 By Drug/Therapy Type
7.2.4.3.2 By Cancer Type
7.2.4.3.3 By Stage
7.3 Europe Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.1 By Drug/Therapy Type
7.3.2 By Cancer Type
7.3.3 By Stage
7.3.4 By Country
7.3.4.1 Germany Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.1.1 By Drug/Therapy Type
7.3.4.1.2 By Cancer Type
7.3.4.1.3 By Stage
7.3.4.2 U.K. Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.2.1 By Drug/Therapy Type
7.3.4.2.2 By Cancer Type
7.3.4.2.3 By Stage
7.3.4.3 France Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.3.1 By Drug/Therapy Type
7.3.4.3.2 By Cancer Type
7.3.4.3.3 By Stage
7.3.4.4 Italy Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.4.1 By Drug/Therapy Type
7.3.4.4.2 By Cancer Type
7.2.4.4.3 By Stage
7.3.4.5 Spain Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.5.1 By Drug/Therapy Type
7.3.4.5.2 By Cancer Type
7.2.4.5.3 By Stage
7.3.4.6 Netherlands Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.6.1 By Drug/Therapy Type
7.3.4.6.2 By Cancer Type
7.2.4.6.3 By Stage
7.3.4.7 Rest of Europe Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.7.1 By Drug/Therapy Type
7.3.4.7.2 By Cancer Type
7.2.4.7.3 By Stage
7.4 Asia Pacific Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.1 By Drug/Therapy Type
7.4.2 By Cancer Type
7.4.3 By Stage
7.4.4 By Country
7.4.4.1 China Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.1.1 By Drug/Therapy Type
7.4.4.1.2 By Cancer Type
7.4.4.1.3 By Stage
7.4.4.2 Japan Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.2.1 By Drug/Therapy Type
7.4.4.2.2 By Cancer Type
7.4.4.2.3 By Stage
7.4.4.3 India Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.3.1 By Drug/Therapy Type
7.4.4.3.2 By Cancer Type
7.4.4.3.3 By Stage
7.4.4.4 South Korea Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.4.1 By Drug/Therapy Type
7.4.4.4.2 By Cancer Type
7.4.4.4.3 By Stage
7.4.4.5 Singapore Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.5.1 By Drug/Therapy Type
7.4.4.5.2 By Cancer Type
7.4.4.5.3 By Stage
7.4.4.6 Malaysia Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.6.1 By Drug/Therapy Type
7.4.4.6.2 By Cancer Type
7.4.4.6.3 By Stage
7.4.4.7 Thailand Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.7.1 By Drug/Therapy Type
7.4.4.7.2 By Cancer Type
7.4.4.7.3 By Stage
7.4.4.8 Indonesia Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.8.1 By Drug/Therapy Type
7.4.4.8.2 By Cancer Type
7.4.4.8.3 By Stage
7.4.4.9 Vietnam Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.9.1 By Drug/Therapy Type
7.4.4.9.2 By Cancer Type
7.4.4.9.3 By Stage
7.4.4.10 Taiwan Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.10.1 By Drug/Therapy Type
7.4.4.10.2 By Cancer Type
7.4.4.10.3 By Stage
7.4.4.11 Rest of Asia Pacific Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.11.1 By Drug/Therapy Type
7.4.4.11.2 By Cancer Type
7.4.4.11.3 By Stage
7.5 Middle East and Africa Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.5.1 By Drug/Therapy Type
7.5.2 By Cancer Type
7.5.3 By Stage
7.5.4 By Country
7.5.4.1 Saudi Arabia Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.5.4.1.1 By Drug/Therapy Type
7.5.4.1.2 By Cancer Type
7.5.4.1.3 By Stage
7.5.4.2 U.A.E. Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.5.4.2.1 By Drug/Therapy Type
7.5.4.2.2 By Cancer Type
7.5.4.2.3 By Stage
7.5.4.3 Israel Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.5.4.3.1 By Drug/Therapy Type
7.5.4.3.2 By Cancer Type
7.5.4.3.3 By Stage
7.5.4.4 South Africa Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.5.4.4.1 By Drug/Therapy Type
7.5.4.4.2 By Cancer Type
7.5.4.4.3 By Stage
7.5.4.5 Rest of Middle East and Africa Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.5.4.5.1 By Drug/Therapy Type
7.5.4.5.2 By Cancer Type
7.5.4.5.2 By Stage
7.6 Central and South America Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.6.1 By Drug/Therapy Type
7.6.2 By Cancer Type
7.6.3 By Stage
7.6.4 By Country
7.6.4.1 Brazil Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.6.4.1.1 By Drug/Therapy Type
7.6.4.1.2 By Cancer Type
7.6.4.1.3 By Stage
7.6.4.2 Argentina Eaporative Air Cooler Market Estimates and Forecast, 2020-2028 (USD Million)
7.6.4.2.1 By Drug/Therapy Type
7.6.4.2.2 By Cancer Type
7.6.4.2.3 By Stage
7.6.4.3 Chile Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.6.4.3.1 By Drug/Therapy Type
7.6.4.3.2 By Cancer Type
7.6.4.3.3 By Stage
7.6.4.4 Rest of Central & South America Oncology Drug Discovery & Development Market Estimates and Forecast, 2020-2028 (USD Million)
7.6.4.4.1 By Drug/Therapy Type
7.6.4.4.2 By Cancer Type
7.6.4.4.3 By Stage
8 COMPETITIVE LANDCAPE
8.1 Company Market Share Analysis
8.2 Four Quadrant Positioning Matrix
8.2.1 Market Leaders
8.2.2 Market Visionaries
8.2.3 Market Challengers
8.2.4 Niche Market Players
8.3 Vendor Landscape
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Rest of the World
8.4 Company Profiles
8.4.1 F. Hoffmann-La Roche Ltd
8.4.1.1 Business Description & Financial Analysis
8.4.1.2 SWOT Analysis
8.4.1.3 Products & Services Offered
8.4.1.4 Strategic Alliances between Business Partners
8.4.2 Novartis
8.4.2.1 Business Description & Financial Analysis
8.4.2.2 SWOT Analysis
8.4.2.3 Products & Services Offered
8.4.2.4 Strategic Alliances between Business Partners
8.4.3 AstraZeneca
8.4.3.1 Business Description & Financial Analysis
8.4.3.2 SWOT Analysis
8.4.3.3 Products & Services Offered
8.4.3.4 Strategic Alliances between Business Partners
8.4.4 Merck & Co., Inc
8.4.4.1 Business Description & Financial Analysis
8.4.4.2 SWOT Analysis
8.4.4.3 Products & Services Offered
8.4.4.4 Strategic Alliances between Business Partners
8.4.5 Bristol-Myers Squibb
8.4.5.1 Business Description & Financial Analysis
8.4.5.2 SWOT Analysis
8.4.5.3 Products & Services Offered
8.4.5.4 Strategic Alliances between Business Partners
8.4.6 Pfizer
8.4.6.1 Business Description & Financial Analysis
8.4.6.2 SWOT Analysis
8.4.6.3 Products & Services Offered
8.4.6.4 Strategic Alliances between Business Partners
8.4.7 Eli Lilly and Company
8.4.7.1 Business Description & Financial Analysis
8.4.7.2 SWOT Analysis
8.4.7.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.8 Gilead Sciences
8.4.8.1 Business Description & Financial Analysis
8.4.8.2 SWOT Analysis
8.4.8.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.9 Regeneron Pharmaceuticals
8.4.9.1 Business Description & Financial Analysis
8.4.9.2 SWOT Analysis
8.4.9.3 Products & Services Offered
8.4.9.4 Strategic Alliances between Business Partners
8.4.10 Takeda Pharmaceutical Company
8.4.10.1 Business Description & Financial Analysis
8.4.10.2 SWOT Analysis
8.4.10.3 Products & Services Offered
8.4.10.4 Strategic Alliances between Business Partners
8.4.11 Other Companies
8.4.11.1 Business Description & Financial Analysis
8.4.11.2 SWOT Analysis
8.4.11.3 Products & Services Offered
8.4.11.4 Strategic Alliances between Business Partners
9 RESEARCH METHODOLOGY
9.1 Market Introduction
9.1.1 Market Definition
9.1.2 Market Scope & Segmentation
9.2 Information Procurement
9.2.1 Secondary Research
9.2.1.1 Purchased Databases
9.2.1.2 GMEs Internal Data Repository
9.2.1.3 Secondary Resources & Third Party Perspectives
9.2.1.4 Company Information Sources
9.2.2 Primary Research
9.2.2.1 Various Types of Respondents for Primary Interviews
9.2.2.2 Number of Interviews Conducted throughout the Research Process
9.2.2.3 Primary Stakeholders
9.2.2.4 Discussion Guide for Primary Participants
9.2.3 Expert Panels
9.2.3.1 Expert Panels Across 30+ Industry
9.2.4 Paid Local Experts
9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
9.3 Market Estimation
9.3.1 Top-Down Approach
9.3.1.1 Macro-Economic Indicators Considered
9.3.1.2 Micro-Economic Indicators Considered
9.3.2 Bottom Up Approach
9.3.2.1 Company Share Analysis Approach
9.3.2.2 Estimation of Potential Product Sales
9.4 Data Triangulation
9.4.1 Data Collection
9.4.2 Time Series, Cross Sectional & Panel Data Analysis
9.4.3 Cluster Analysis
9.5 Analysis and Output
9.5.1 Inhouse AI Based Real Time Analytics Tool
9.5.2 Output From Desk & Primary Research
9.6 Research Assumptions & Limitations
9.7.1 Research Assumptions
9.7.2 Research Limitations
LIST OF TABLES
1 Global Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Mllion)
2 Chemotherapy Market, By Region, 2020-2028 (USD Mllion)
3 Targeted Therapy Market, By Region, 2020-2028 (USD Mllion)
4 Immunotherapy Market, By Region, 2020-2028 (USD Mllion)
5 Hormone Therapy Market, By Region, 2020-2028 (USD Mllion)
6 Others Market, By Region, 2020-2028 (USD Mllion)
7 Global Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Mllion)
8 Lung Cancer Market, By Region, 2020-2028 (USD Mllion)
9 Breast Cancer Market, By Region, 2020-2028 (USD Mllion)
10 Colorectal Cancer Market, By Region, 2020-2028 (USD Mllion)
11 Prostate Cancer Market, By Region, 2020-2028 (USD Mllion)
12 Leukemia Cancer Market, By Region, 2020-2028 (USD Mllion)
13 Lymphoma Cancer Market, By Region, 2020-2028 (USD Mllion)
14 Ovarian Cancer Market, By Region, 2020-2028 (USD Mllion)
15 Others Market, By Region, 2020-2028 (USD Mllion)
16 Global Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Mllion)
17 Discovery Phase Market, By Region, 2020-2028 (USD Mllion)
18 Preclinical Phase Market, By Region, 2020-2028 (USD Mllion)
19 Clinical Trials & Others Market, By Region, 2020-2028 (USD Mllion)
20 Regional Analysis, 2020-2028 (USD Mllion)
21 North America Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
22 North America Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
23 North America Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
24 North America Oncology Drug Discovery & Development Market, By Country, 2020-2028 (USD Million)
25 U.S Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
26 U.S Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
27 U.S Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
28 Canada Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
29 Canada Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
30 Canada Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
31 Mexico Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
32 Mexico Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
33 Mexico Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
34 Europe Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
35 Europe Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
36 Europe Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
37 Germany Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
38 Germany Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
39 Germany Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
40 U.K Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
41 U.K Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
42 U.K Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
43 France Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
44 France Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
45 France Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
46 Italy Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
47 Italy Oncology Drug Discovery & Development Market, By End Use , 2020-2028 (USD Million)
48 Italy Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
49 Spain Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
50 Spain Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
51 Spain Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
52 Rest Of Europe Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
53 Rest Of Europe Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
54 Rest of Europe Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
55 Asia Pacific Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
56 Asia Pacific Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
57 Asia Pacific Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
58 Asia Pacific Oncology Drug Discovery & Development Market, By Country, 2020-2028 (USD Million)
59 China Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
60 China Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
61 China Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
62 India Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
63 India Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
64 India Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
65 Japan Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
66 Japan Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
67 Japan Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
68 South Korea Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
69 South Korea Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
70 South Korea Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
71 Middle East and Africa Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
72 Middle East and Africa Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
73 Middle East and Africa Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
74 Middle East and Africa Oncology Drug Discovery & Development Market, By Country, 2020-2028 (USD Million)
75 Saudi Arabia Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
76 Saudi Arabia Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
77 Saudi Arabia Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
78 UAE Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
79 UAE Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
80 UAE Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
81 Central and South America Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
82 Central and South America Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
83 Central and South America Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
84 Central and South America Oncology Drug Discovery & Development Market, By Country, 2020-2028 (USD Million)
85 Brazil Oncology Drug Discovery & Development Market, By Drug/Therapy Type, 2020-2028 (USD Million)
86 Brazil Oncology Drug Discovery & Development Market, By Cancer Type, 2020-2028 (USD Million)
87 Brazil Oncology Drug Discovery & Development Market, By Stage, 2020-2028 (USD Million)
88 F. Hoffmann-La Roche Ltd: Products & Services Offering
89 Novartis: Products & Services Offering
90 AstraZeneca: Products & Services Offering
91 Merck & Co., Inc: Products & Services Offering
92 Bristol-Myers Squibb: Products & Services Offering
93 PFIZER: Products & Services Offering
94 Eli Lilly and Company : Products & Services Offering
95 Gilead Sciences: Products & Services Offering
96 Regeneron Pharmaceuticals, Inc: Products & Services Offering
97 Takeda Pharmaceutical Company: Products & Services Offering
98 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Oncology Drug Discovery & Development Market Overview
2 Global Oncology Drug Discovery & Development Market Value From 2020-2028 (USD Mllion)
3 Global Oncology Drug Discovery & Development Market Share, By Drug/Therapy Type (2022)
4 Global Oncology Drug Discovery & Development Market Share, By Cancer Type (2022)
5 Global Oncology Drug Discovery & Development Market Share, By Stage (2022)
6 Global Oncology Drug Discovery & Development Market, By Region (Asia Pacific Market)
7 Technological Trends In Global Oncology Drug Discovery & Development Market
8 Four Quadrant Competitor Positioning Matrix
9 Impact Of Macro & Micro Indicators On The Market
10 Impact Of Key Drivers On The Global Oncology Drug Discovery & Development Market
11 Impact Of Challenges On The Global Oncology Drug Discovery & Development Market
12 Porter’s Five Forces Analysis
13 Global Oncology Drug Discovery & Development Market: By Drug/Therapy Type Scope Key Takeaways
14 Global Oncology Drug Discovery & Development Market, By Drug/Therapy Type Segment: Revenue Growth Analysis
15 Chemotherapy Market, By Region, 2020-2028 (USD Mllion)
16 Targeted Therapy Market, By Region, 2020-2028 (USD Mllion)
17 Immunotherapy Market, By Region, 2020-2028 (USD Mllion)
18 Hormone Therapy Market, By Region, 2020-2028 (USD Mllion)
19 Others Market, By Region, 2020-2028 (USD Mllion)
20 Global Oncology Drug Discovery & Development Market: By Cancer Type Scope Key Takeaways
21 Global Oncology Drug Discovery & Development Market, By Cancer Type Segment: Revenue Growth Analysis
22 Lung Cancer Market, By Region, 2020-2028 (USD Mllion)
23 Breast Cancer Market, By Region, 2020-2028 (USD Mllion)
24 Colorectal Cancer Market, By Region, 2020-2028 (USD Mllion)
25 Prostate Cancer Market, By Region, 2020-2028 (USD Mllion)
26 Leukemia Cancer Market, By Region, 2020-2028 (USD Mllion)
27 Lymphoma Cancer Market, By Region, 2020-2028 (USD Mllion)
28 Ovarian Cancer Market, By Region, 2020-2028 (USD Mllion)
29 Others Market, By Region, 2020-2028 (USD Mllion)
30 Global Oncology Drug Discovery & Development Market: By Stage Scope Key Takeaways
31 Global Oncology Drug Discovery & Development Market, By Stage Segment: Revenue Growth Analysis
32 Discovery Phase Market, By Region, 2020-2028 (USD Mllion)
33 Preclinical Phase Market, By Region, 2020-2028 (USD Mllion)
34 Clinical Trials & Others Market, By Region, 2020-2028 (USD Mllion)
35 Regional Segment: Revenue Growth Analysis
36 Global Oncology Drug Discovery & Development Market: Regional Analysis
37 North America Oncology Drug Discovery & Development Market Overview
38 North America Oncology Drug Discovery & Development Market, By Drug/Therapy Type
39 North America Oncology Drug Discovery & Development Market, By Cancer Type
40 North America Oncology Drug Discovery & Development Market, By Stage
41 North America Oncology Drug Discovery & Development Market, By Country
42 U.S. Oncology Drug Discovery & Development Market, By Drug/Therapy Type
43 U.S. Oncology Drug Discovery & Development Market, By Cancer Type
44 U.S. Oncology Drug Discovery & Development Market, By Stage
45 Canada Oncology Drug Discovery & Development Market, By Drug/Therapy Type
46 Canada Oncology Drug Discovery & Development Market, By Cancer Type
47 Canada Oncology Drug Discovery & Development Market, By Stage
48 Mexico Oncology Drug Discovery & Development Market, By Drug/Therapy Type
49 Mexico Oncology Drug Discovery & Development Market, By Cancer Type
50 Mexico Oncology Drug Discovery & Development Market, By Stage
51 Four Quadrant Positioning Matrix
52 Company Market Share Analysis
53 F. Hoffmann-La Roche Ltd: Company Snapshot
54 F. Hoffmann-La Roche Ltd: SWOT Analysis
55 F. Hoffmann-La Roche Ltd: Geographic Presence
56 Novartis: Company Snapshot
57 Novartis: SWOT Analysis
58 Novartis: Geographic Presence
59 AstraZeneca: Company Snapshot
60 AstraZeneca: SWOT Analysis
61 AstraZeneca: Geographic Presence
62 Merck & Co., Inc: Company Snapshot
63 Merck & Co., Inc: Swot Analysis
64 Merck & Co., Inc: Geographic Presence
65 Bristol-Myers Squibb: Company Snapshot
66 Bristol-Myers Squibb: SWOT Analysis
67 Bristol-Myers Squibb: Geographic Presence
68 Pfizer: Company Snapshot
69 Pfizer: SWOT Analysis
70 Pfizer: Geographic Presence
71 Eli Lilly and Company : Company Snapshot
72 Eli Lilly and Company : SWOT Analysis
73 Eli Lilly and Company : Geographic Presence
74 Gilead Sciences: Company Snapshot
75 Gilead Sciences: SWOT Analysis
76 Gilead Sciences: Geographic Presence
77 Regeneron Pharmaceuticals, Inc.: Company Snapshot
78 Regeneron Pharmaceuticals, Inc.: SWOT Analysis
79 Regeneron Pharmaceuticals, Inc.: Geographic Presence
80 Takeda Pharmaceutical Company: Company Snapshot
81 Takeda Pharmaceutical Company: SWOT Analysis
82 Takeda Pharmaceutical Company: Geographic Presence
83 Other Companies: Company Snapshot
84 Other Companies: SWOT Analysis
85 Other Companies: Geographic Presence
The Global Oncology Drug Discovery & Development Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Oncology Drug Discovery & Development Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
